{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-034342","form_type":"8-K","ticker":null,"cik":"0000786947","company_name":"ACURA PHARMACEUTICALS, INC","filed_at":"2023-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.086504+00:00","generated_at":"2026-06-17T23:20:59.302379+00:00","sec_items":["1.01","2.01","2.03"],"event_type":"debt","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Acura Pharmaceuticals secures $250K related-party loan; warns of possible operations cessation","bullets":["Received $250,000 loan from AD Pharma, controlled by Mr. Schutte, increasing total debt to $3,319,279 at 5.25% interest, maturing Dec 31, 2023.","Proceeds will fund operations only through April 2023; warns that without additional financing it may scale back or cease operations.","AD Pharma directly owns ~66% of common stock; Mr. Schutte owns ~14% directly; loan is a related-party transaction.","Default interest rate of 7.5% applies to overdue amounts; events of default include bankruptcy and payment failure for 5 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-034342","json":"https://secwatch.observer/filing/0001104659-23-034342.json","markdown":"https://secwatch.observer/filing/0001104659-23-034342.md","text":"https://secwatch.observer/filing/0001104659-23-034342.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/786947/000110465923034342/0001104659-23-034342-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/786947/000110465923034342/tm2310020d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T23:20:59.302379+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"084e2c4b5886232a903a43e720bcc2704be8f4fb","claim":"ACURA PHARMACEUTICALS, INC incurred loan of $250,000 with Abuse Deterrent Pharma, LLC at 5.25% maturing December 31, 2023.","evidence_excerpt":"On March 20, 2023 we received a $250,000 loan from Abuse Deterrent Pharma, LLC (“AD Pharma”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/786947/000110465923034342/0001104659-23-034342-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$250,000"},{"label":"Counterparty","value":"Abuse Deterrent Pharma, LLC"},{"label":"Rate","value":"5.25%"},{"label":"Maturity","value":"December 31, 2023"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}